CVS Health Corp operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CVS Health Corp with three other
drug stores in North America:
McKesson Corporation
(2019
sales of $214.32 billion
of which 78%
was U.S. Pharmaceutical and Specialty Soluti),
AmerisourceBergen Corporation
($179.59 billion
of which 96%
was Pharmaceutical Distribution), and
Cardinal Health, Inc.
($145.53 billion
of which 89%
was Pharmaceutical).
Sales Analysis.
CVS Health Corp reported sales of $256.78 billion
for the
year ending
December of 2019.
This
represents
an
increase of 32.0%
versus 2018, when the company's sales were $194.58 billion.
Sales at CVS Health Corp have increased during each of the previous five years
(and since 2014, sales have increased a total of 84%).
Sales of Healthcare Benefits saw an increase
that was more than double the company's growth rate: sales were up
1,154.4% in 2019, from
$5.55 billion to $69.60 billion.
Not all segments of CVS Health Corp experienced an increase in sales in 2019:
sales of Corporate Segment fell 15.5% to $512.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).